GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite

GE HealthCare (Nasdaq: GEHC) today announced that Allia™ Moveo has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking, bringing next-level mobility and precision to the ...
ZAWYA

FUJIFILM Middle East launches cutting-edge interventional cardiology solutions in MEA in collaboration with Innvolution Healthcare

This strategic move will enable wider access to world-class interventional cardiology technologies across the Middle East and ...